BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 12960329)

  • 1. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.
    Wright GJ; Cherwinski H; Foster-Cuevas M; Brooke G; Puklavec MJ; Bigler M; Song Y; Jenmalm M; Gorman D; McClanahan T; Liu MR; Brown MH; Sedgwick JD; Phillips JH; Barclay AN
    J Immunol; 2003 Sep; 171(6):3034-46. PubMed ID: 12960329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor.
    Hatherley D; Cherwinski HM; Moshref M; Barclay AN
    J Immunol; 2005 Aug; 175(4):2469-74. PubMed ID: 16081818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules.
    Gorczynski R; Chen Z; Kai Y; Lee L; Wong S; Marsden PA
    J Immunol; 2004 Jun; 172(12):7744-9. PubMed ID: 15187158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of agonistic and blocking effects of CD200 receptor antibodies.
    Akkaya M; Aknin ML; Akkaya B; Barclay AN
    PLoS One; 2013; 8(5):e63325. PubMed ID: 23691022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human cd200 glycoprotein receptor gene located on chromosome 3q12-13.
    Vieites JM; de la Torre R; Ortega MA; Montero T; Peco JM; Sánchez-Pozo A; Gil A; Suárez A
    Gene; 2003 Jun; 311():99-104. PubMed ID: 12853143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of CD200 inhibition of mast cell activation.
    Zhang S; Cherwinski H; Sedgwick JD; Phillips JH
    J Immunol; 2004 Dec; 173(11):6786-93. PubMed ID: 15557172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains.
    Hatherley D; Barclay AN
    Eur J Immunol; 2004 Jun; 34(6):1688-94. PubMed ID: 15162439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules and their expression at the feto-maternal interface.
    Gorczynski RM; Chen Z; Clark DA; Kai Y; Lee L; Nachman J; Wong S; Marsden P
    Am J Reprod Immunol; 2004 Aug; 52(2):147-63. PubMed ID: 15274657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor.
    Foster-Cuevas M; Wright GJ; Puklavec MJ; Brown MH; Barclay AN
    J Virol; 2004 Jul; 78(14):7667-76. PubMed ID: 15220441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?
    Minas K; Liversidge J
    Crit Rev Immunol; 2006; 26(3):213-30. PubMed ID: 16928187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.
    Mihrshahi R; Brown MH
    J Immunol; 2010 Dec; 185(12):7216-22. PubMed ID: 21078907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats.
    Banerjee D; Dick AD
    Ocul Immunol Inflamm; 2004 Jun; 12(2):115-25. PubMed ID: 15512981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.
    Walker DG; Dalsing-Hernandez JE; Campbell NA; Lue LF
    Exp Neurol; 2009 Jan; 215(1):5-19. PubMed ID: 18938162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD200 and membrane protein interactions in the control of myeloid cells.
    Barclay AN; Wright GJ; Brooke G; Brown MH
    Trends Immunol; 2002 Jun; 23(6):285-90. PubMed ID: 12072366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD200 receptor is a novel and potent regulator of murine and human mast cell function.
    Cherwinski HM; Murphy CA; Joyce BL; Bigler ME; Song YS; Zurawski SM; Moshrefi MM; Gorman DM; Miller KL; Zhang S; Sedgwick JD; Phillips JH
    J Immunol; 2005 Feb; 174(3):1348-56. PubMed ID: 15661892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.
    Mihrshahi R; Barclay AN; Brown MH
    J Immunol; 2009 Oct; 183(8):4879-86. PubMed ID: 19786546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells.
    Fournier N; Chalus L; Durand I; Garcia E; Pin JJ; Churakova T; Patel S; Zlot C; Gorman D; Zurawski S; Abrams J; Bates EE; Garrone P
    J Immunol; 2000 Aug; 165(3):1197-209. PubMed ID: 10903717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrete monoclonal antibodies define functionally important epitopes in the CD200 molecule responsible for immunosuppression function.
    Chen DX; Gorczynski RM
    Transplantation; 2005 Feb; 79(3):282-8. PubMed ID: 15699757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the chicken CD200 receptor family.
    Viertlboeck BC; Hanczaruk MA; Schmitt FC; Schmitt R; Göbel TW
    Mol Immunol; 2008 Apr; 45(7):2097-105. PubMed ID: 18062907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing.
    Meuth SG; Simon OJ; Grimm A; Melzer N; Herrmann AM; Spitzer P; Landgraf P; Wiendl H
    J Neuroimmunol; 2008 Feb; 194(1-2):62-9. PubMed ID: 18164423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.